Build a stronger case for your therapy’s value with real-world evidence
Atropos Health partners with HEOR and market access teams to generate rigorous real-world evidence across comparative effectiveness, healthcare costs, and disease burden. Our studies align with brand strategy and support evidence needs throughout the product lifecycle.
%
success rate in publishing studies in peer-reviewed journals
precision findings in our evidence library
longitudinal patient timelines across the Atropos Evidence™ Network
How Atropos Works
Formulate the clinical protocol
Your team defines the general study goal and parameters. If you have more detail, it is incorporated. If not, our team of medical informatics experts help you design an effective and clinically valid study from idea through protocol, results, and final publication.
Score your data fitness upfront
Assess cohort feasibility and data appropriateness across the Atropos Evidence™ Network prior to study execution. Built-in fitness scoring verifies patient density, longitudinal completeness, and covariate coverage—saving you time and money on inadequate datasets.
Run advanced analytics
Generate robust real-world evidence across key health economic study designs, including comparative effectiveness, total cost of care, burden of illness, and treatment sequencing. Atropos evaluates side-by-side cohort models (Unmatched, Basic Matched, and Propensity Score Matched) alongside E-value sensitivity reporting.
Deploy Submission-ready evidence
Receive comprehensive, transparent analytical reports complete with fully documented methodologies. Every output transitions seamlessly into payor dossiers, HTA submissions, medical response letters, or peer-reviewed manuscripts.
Your team stays in control
You define the core clinical parameters
Our medical informatics and biostatistics teams collaborate with you to refine protocols whenever you need secondary oversight.
You audit every method
No black boxes. Your team retains full visibility into underlying cohort definitions, covariate selections, propensity matching logic, and executable analytical code for total reproducibility.
You own the deliverables
You retain complete ownership of all analytical outputs, structured data tables, and fully documented methodology sections.
Multimodal real-world data built for depth, linked for context, and scored for fitness
HEOR and Market Access studies require more than superficial claims tracking; they demand longitudinal clinical context. The Atropos Evidence Network provides unified, federated access across 894M+ longitudinal patient timelines, combining longitudinal EHR, open and closed claims, clinical labs, registries, and unstructured clinical notes. Using secure nodal linkage, you analyze complete patient journeys across care settings without moving raw source data.
Scored fitness upfront
Eliminate dataset purchasing risk. Every dataset carries a Real World Fitness Score® that evaluates data readiness, cohort density, and variable coverage before you execute your study.
Federated access and flexibility
Analyze internal data behind your firewall, tap the Atropos Evidence Network for national scale, or do both through a single analytical platform.
Publication-grade RWE built to withstand peer review and congress scrutiny
Bring us the evidence question your next payer conversation depends on
Tell us the therapy, the comparator, and the decision ahead. We will show you which datasets can answer it and what the study would include.